CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 48,440 shares at $17.56 ($851K) on 2016-06-06, disclosed to the SEC on 2016-06-08.
Open-market purchase of $851k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.56 | 1,090 | $19K | 2.2% |
| 2 | $17.56 | 1,260 | $22K | 2.6% |
| 3 | $17.56 | 1,610 | $28K | 3.3% |
| 4 | $17.56 | 4,580 | $80K | 9.4% |
| 5 | $17.56 | 4,810 | $84K | 9.9% |
| 6 | $17.56 | 6,650 |
| $117K |
| 13.7% |
| 7 | $17.56 | 4,810 | $84K | 9.9% |
| 8 | $17.56 | 1,090 | $19K | 2.2% |
| 9 | $17.56 | 4,580 | $80K | 9.4% |
| 10 | $17.56 | 1,260 | $22K | 2.6% |
| 11 | $17.56 | 6,650 | $117K | 13.7% |
| 12 | $17.56 | 1,610 | $28K | 3.3% |
| 13 | $17.62 | 230 | $4K | 0.5% |
| 14 | $17.62 | 270 | $5K | 0.6% |
| 15 | $17.62 | 340 | $6K | 0.7% |
| 16 | $17.62 | 970 | $17K | 2.0% |
| 17 | $17.62 | 1,010 | $18K | 2.1% |
| 18 | $17.62 | 1,400 | $25K | 2.9% |
| 19 | $17.62 | 1,010 | $18K | 2.1% |
| 20 | $17.62 | 230 | $4K | 0.5% |
| 21 | $17.62 | 970 | $17K | 2.0% |
| 22 | $17.62 | 270 | $5K | 0.6% |
| 23 | $17.62 | 1,400 | $25K | 2.9% |
| 24 | $17.62 | 340 | $6K | 0.7% |
| Total | $17.57 avg | 48,440 | $851K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |